Apitegromab BLA Moves to One Fill-Finish Facility

Company: Scholar Rock · Event Type: Clinical/Regulatory Signal · Product/Asset: apitegromab · Subject: Spinal Muscular Atrophy · Event Date: August 7, 2026 Summary Scholar Rock will remove Catalent Indiana from the apitegromab biologics license application after FDA classified the site’s April inspection as Official Action…